PBE Holdings List

As of Jun 28, 2024

No.	Symbol	Name	% Weight	Shares
1	BMRN	BioMarin Pharmaceutical Inc.	5.39%	168,781
2	REGN	Regeneron Pharmaceuticals, Inc.	5.27%	12,909
3	GILD	Gilead Sciences, Inc.	5.23%	196,472
4	INCY	Incyte Corporation	5.16%	219,430
5	VRTX	Vertex Pharmaceuticals Incorporated	5.11%	28,111
6	AMGN	Amgen Inc.	5.07%	41,848
7	ILMN	Illumina, Inc.	4.97%	122,693
8	NBIX	Neurocrine Biosciences, Inc.	4.78%	89,425
9	IONS	Ionis Pharmaceuticals, Inc.	3.37%	182,046
10	HALO	Halozyme Therapeutics, Inc.	3.23%	159,058
11	UTHR	United Therapeutics Corporation	3.15%	25,459
12	MNKD	MannKind Corporation	3.00%	1,479,959
13	IRWD	Ironwood Pharmaceuticals, Inc.	2.95%	1,165,342
14	EXEL	Exelixis, Inc.	2.94%	336,884
15	TGTX	TG Therapeutics, Inc.	2.81%	406,659
16	BPMC	Blueprint Medicines Corporation	2.80%	66,942
17	MYGN	Myriad Genetics, Inc.	2.79%	293,834
18	ITCI	Intra-Cellular Therapies, Inc.	2.78%	104,422
19	VCYT	Veracyte, Inc.	2.69%	319,450
20	DVAX	Dynavax Technologies Corporation	2.60%	595,844
21	VCEL	Vericel Corporation	2.54%	142,844
22	QIA.DE	QIAGEN NV	2.54%	159,280
23	COLL	Collegium Pharmaceutical, Inc.	2.49%	199,366
24	CPRX	Catalyst Pharmaceuticals, Inc.	2.49%	413,531
25	OPK	OPKO Health, Inc.	2.44%	5,038,391
26	SAGE	Sage Therapeutics, Inc.	2.42%	574,368
27	TECH	Bio-Techne Corporation	2.40%	86,311
28	PTCT	PTC Therapeutics, Inc.	2.23%	187,886
29	XNCR	Xencor, Inc.	2.15%	292,829
30	RGEN	Repligen Corporation	2.14%	43,714
31	AGPXX	Invesco Government & Agency Portfolio	0.09%	225,201
32	-CASH-	Cash/Receivables/Payables	0.00%	5,728

As of Jun 28, 2024